Status:
NOT_YET_RECRUITING
Study of Abnormally Fertilized Embryos
Lead Sponsor:
Igenomix
Conditions:
Infertility (IVF Patients)
Eligibility:
All Genders
18-49 years
Brief Summary
The goal of this observational study is to determine the diploidy rate of haploid and triploid embryos from in vitro fertilization (IVF) cycles. The main questions it aims to answer are: * Can a mole...
Detailed Description
Chromosomes are cellular structures containing the majority of the genetic information of a living organism. Gametes (oocytes and spermatozoa) contain only a single set of 23 chromosomes within struct...
Eligibility Criteria
Inclusion
- ART patients who sign the Informed Consent of the study.
- Age: oocytes from women ≤ 49 years and semen from men ≤ 60 years. Donation of gametes is allowed.
- ≥1 blastocysts from oocytes with an abnormal pronuclear pattern (1PN, 2.1PN, and/or 3PN) and with the presence of 2 polar bodies (PB), cultured in a time-lapse incubator.
Exclusion
- No exclusion criteria have been considered for this study.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06940973
Start Date
April 1 2025
End Date
September 1 2026
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Equipo Médico Crespo Valencia
Valencia, Valencia, Spain, 46015